Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Prepaid Assets came in at $1.4 million in Q1 2026, down 19.33% year-on-year from $1.8 million in Q1 2025, and up 45.67% on a QoQ basis from $994000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 7 years of Prepaid Assets data on file, last reported at $1.4 million in Q1 2026.
- On a quarterly basis, Prepaid Assets fell 19.33% year-over-year to $1.4 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 19.33% decrease from a year earlier, with the FY2025 full-year figure at $994000.0, down 52.53% from the prior year.
- Prepaid Assets for Q1 2026 stood at $1.4 million, up from $994000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for OBIO reached as high as $2.3 million in Q1 2023 and fell as low as $36417.0 in Q2 2022.
- Historically, Prepaid Assets has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
- Across the five-year window, Prepaid Assets sank 65.54% in 2022 and jumped 3931.08% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $533000.0 in 2022, then soared by 139.02% to $1.3 million in 2023, then soared by 64.36% to $2.1 million in 2024, then plunged by 52.53% to $994000.0 in 2025, then jumped by 45.67% to $1.4 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $1.4 million in Q1 2026, $994000.0 in Q4 2025, and $1.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.45 Mn |
| Dec 31, 2025 | 994,000.00 |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.69 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 1.21 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 533,000.00 |
| Sep 30, 2022 | 137,338.00 |
| Jun 30, 2022 | 36,417.00 |
| Mar 31, 2022 | 71,292.00 |
| Dec 31, 2021 | 46,667.00 |
| Sep 30, 2021 | 81,167.00 |
| Jun 30, 2021 | 105,667.00 |